key articles
Testosterone therapy in hypogonadal men and potential prostate cancer risk: a systematic review
Sunday, 10 August 2008 - Shabsigh et al. (2008) systematically reviewed the literature about prostate cancer risk associated with testosterone therapy for hypogonadism.
A comprehensive search of MEDLINE, EMBASE and other...
Authors: Shabsigh et al.
Dark side of testosterone deficiency: Metabolic syndrome and erectile dysfunction
Saturday, 9 August 2008 - Metabolic Syndrome (MetS) is the most important public health threat of the 21st Century. This syndrome is characterized by a cluster of cardiovascular risk factors including increased central abdominal...
Authors: Traish et al.
Transperineal microwave thermoablation in patients with obstructive benign prostatic hyperplasia
Tuesday, 5 August 2008 - Bartoletti et al. (2008) evaluated the tolerability and safety of a newly designed probe for trans-perineal microwave thermoablation (TPMT) of the prostate in patients with benign prostatic hyperplasia...
Authors: Bartoletti et al.
Sildenafil citrate (Viagra) improves erectile function and lower urinary tract symptoms
Friday, 1 August 2008 - McVary et al. (2008) evaluated the body mass index (BMI) and lower urinary tract symptom (LUTS) severity on treatment response to sildenafil in men with erectile dysfunction (ED) and moderate to severe...
Authors: McVary et al.
Association between lower urinary tract symptoms and serum sex hormones in men
Friday, 1 August 2008 - Despite the well-known association between lower urinary tract symptoms (LUTS) and male sexual dysfunction, few data are available that describe the relationship between LUTS and sex hormones. Miwa et al....
Authors: Miwa et al.
Progression of benign prostatic hyperplasia
Wednesday, 9 July 2008 - Emberton et al. (2008) systematically reviewed the placebo arms of randomized trials of medical therapy for benign prostatic hyperplasia (BPH) and thus estimate rates of progression.
The authors searched...
Authors: Emberton et al.
Functional outcome following photoselective vaporisation of the prostate: urodynamic findings of 12 months follow-up
Monday, 23 June 2008 - Hamann et al. (2008) determined the impact of potassium-titanyl-phosphate (KTP) laser therapy of the prostate on urodynamic results, voiding function, quality of life, and sexual function.
Forty-five...
Authors: Hamann et al.
Transurethral ethanol ablation of prostate: an effective minimally invasive option
Wednesday, 18 June 2008 - Magno et al. (2008) evaluated the efficacy and safety of transurethral ethanol ablation of the prostate (TEAP) for patients with symptomatic benign prostatic hyperplasia (BPH) and high-risk...
Authors: Magno et al.
High-power potassium-titanyl-phosphate laser photoselective vaporization prostatectomy
Tuesday, 17 June 2008 - Potassium-titanyl-phosphate (KTP) laser photoselective vaporization prostatectomy (PVP) is a relatively new technology for the management of lower urinary-tract symptoms (LUTS) secondary to benign...
Authors: Araki et al.
Guide to risk factors and options for management of benign prostatic hyperplasia
Tuesday, 17 June 2008 - In a review, Emberton et al. (2008) discussed current knowledge of the progressive nature of benign prostatic hyperplasia (BPH) and how the risk of BPH progression can be evaluated toguide therapeutic...
Authors: Emberton et al.
